Aster Capital Management’s Zenas BioPharma ZBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.2K Buy
+378
New +$11.6K ﹤0.01% 777
2026
Q1
– Sell
-42
Closed -$1.52K – 1423
2025
Q4
$1.52K Sell
42
-297
-88% -$9.8K ﹤0.01% 982
2025
Q3
$7.53K Buy
+339
New +$5.52K ﹤0.01% 775
2024
Q4
– Sell
-3,018
Closed -$51.1K – 1601
2024
Q3
$51.1K Buy
+3,018
New +$54.3K 0.01% 497

Other funds holding ZBIO

Aster Capital Management's ZBIO Position: Q3 2026 in Review

Aster Capital Management opened a new position in Zenas BioPharma (ZBIO) in Q3 2026: 378 shares worth $10.2K. The stake represents ﹤0.01% of the portfolio and ranks #777 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in ZBIO as recently as Q4 2025.

Aster Capital Management first reported a position in ZBIO in Q3 2024 and has held it in 4 quarters since. The position peaked at $51.1K in Q3 2024. 153 funds tracked by Wall St. Rank hold ZBIO as of Q3 2026.

  • Aster Capital Management held 378 shares of Zenas BioPharma worth $10.2K as of Q3 2026.
  • Zenas BioPharma was a new Aster Capital Management position in Q3 2026.
  • Zenas BioPharma made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #777 holding.
  • Aster Capital Management first reported a position in Zenas BioPharma in Q3 2024 and has held it in 4 quarters since.
  • Aster Capital Management's Zenas BioPharma position peaked at $51.1K in Q3 2024.
  • 153 funds tracked by Wall St. Rank held Zenas BioPharma as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.